Thalidomide-O-PEG-Propargyl Ester is a chemical compound that has been developed as an anti-cancer therapeutic agent. It is a new form of thalidomide, a pharmaceutical originally developed to treat morning sickness in pregnant women. The new compound is an ester of thalidomide and polyethylene glycol propargyl ether (PEG-PA), which is a chemical with the ability to bind to certain proteins in the body and decrease their activity. This could help reduce the growth of tumor cells in cancer patients.
ADC Technologies & Analytical Services & Worldwide Leading PEG Supplier
- Home
- Services
- Products
- Acid PEG
- Aldehyde PEG
- Alkyne PEG
- Amino PEG
- Aminooxy PEG
- APN Linkers
- Azide PEG
- BCN-PEG
- Benzyl-PEG
- Biotin PEG
- Bis-PEG-NHS
- Bis-PEG-acid
- Bis-Sulfone PEG
- Boc-PEG
- Branched PEG
- Bromo PEG
- Cleavable Linkers
- DBCO PEG
- DNP PEG
- DOTA PEG
- DSPE PEG
- Diketone PEG
- Fluorescent PEG
- Fmoc PEG
- Folate PEG
- Homobifunctional PEG
- HyNic PEG
- Hydrazide PEG
- Hydroxy PEG
- Iodo PEG
- Lipid PEG
- M-PEG
- Maleimide PEG
- MeNH-PEG
- NHS ester PEG
- Non-PEG linker
- PEG-X-PEG
- PEG-t-butyl ester
- PFP ester PEG
- PROTAC PEG
- Peptide Linkers
- Phosphonate PEG
- Polymer PEG
- Propargyl PEG
- SPDP PEG
- Silane PEG
- Sugar PEG
- Sulfonic acid PEG
- TCO PEG
- Tetrazine PEG
- Thiol PEG
- Tosylate PEG
- Instrumentation
- Quick Links
- Blog
- Contact Us
